318 related articles for article (PubMed ID: 15505129)
1. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.
Levitan EB; Song Y; Ford ES; Liu S
Arch Intern Med; 2004 Oct; 164(19):2147-55. PubMed ID: 15505129
[TBL] [Abstract][Full Text] [Related]
2. Fasting and postchallenge hyperglycemia and risk of cardiovascular disease in Chinese: the Chin-Shan Community Cardiovascular Cohort study.
Chien KL; Hsu HC; Su TC; Chen MF; Lee YT; Hu FB
Am Heart J; 2008 Nov; 156(5):996-1002. PubMed ID: 19061718
[TBL] [Abstract][Full Text] [Related]
3. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
5. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study.
Jee SH; Boulware LE; Guallar E; Suh I; Appel LJ; Miller ER
Arch Intern Med; 2005 Oct; 165(19):2299-304. PubMed ID: 16246998
[TBL] [Abstract][Full Text] [Related]
6. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of hyperglycemia and cancer risk.
Stattin P; Björ O; Ferrari P; Lukanova A; Lenner P; Lindahl B; Hallmans G; Kaaks R
Diabetes Care; 2007 Mar; 30(3):561-7. PubMed ID: 17327321
[TBL] [Abstract][Full Text] [Related]
10. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.
Ninomiya T; Kiyohara Y; Tokuda Y; Doi Y; Arima H; Harada A; Ohashi Y; Ueshima H;
Circulation; 2008 Dec; 118(25):2694-701. PubMed ID: 19106392
[TBL] [Abstract][Full Text] [Related]
11. Women in Pakistan have a greater burden of clinical cardiovascular risk factors than men.
Jafar TH
Int J Cardiol; 2006 Jan; 106(3):348-54. PubMed ID: 16337043
[TBL] [Abstract][Full Text] [Related]
12. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
[TBL] [Abstract][Full Text] [Related]
13. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
[TBL] [Abstract][Full Text] [Related]
14. Fasting glucose and cardiovascular risk factors in an urban population.
Gupta R; Sarna M; Thanvi J; Sharma V; Gupta VP
J Assoc Physicians India; 2007 Oct; 55():705-9. PubMed ID: 18173023
[TBL] [Abstract][Full Text] [Related]
15. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
16. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
[TBL] [Abstract][Full Text] [Related]
17. Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men.
Czernichow S; Bruckert E; Bertrais S; Galan P; Hercberg S; Oppert JM
Int J Obes (Lond); 2007 May; 31(5):791-6. PubMed ID: 17047639
[TBL] [Abstract][Full Text] [Related]
18. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease.
Kshirsagar AV; Carpenter M; Bang H; Wyatt SB; Colindres RE
Am J Med; 2006 Feb; 119(2):133-41. PubMed ID: 16443415
[TBL] [Abstract][Full Text] [Related]
20. Blood glucose: a strong risk factor for mortality in nondiabetic patients with cardiovascular disease.
Port SC; Goodarzi MO; Boyle NG; Jennrich RI
Am Heart J; 2005 Aug; 150(2):209-14. PubMed ID: 16086919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
